The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Blanchard Cheryl R since 2007.
This trader's CIK number is 1326530.
At the time of last reporting, Blanchard Cheryl R was the President, CEO, Director of Anika Therapeutics, Inc.. (stock ticker symbol ANIK).
Also see all insider trading activities at Anika Therapeutics, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2012 | ZMH | 0 | $0 | 12,000 | $660,000 | 19,162 | $474,360 |
| 2011 | ZMH | 0 | $0 | 4,000 | $260,000 | 6,794 | $120,760 |
| 2009 | ZMH | 0 | $0 | 0 | $0 | 6,813 | $0 |
| 2008 | ZMH | 0 | $0 | 0 | $0 | 6,812 | $0 |
| 2007 | ZMH | 0 | $0 | 19,856 | $1,677,645 | 19,856 | $605,923 |
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2025 | ANIK | 0 | $0 | 0 | $0 | 75,194 | $0 |
| 2024 | ANIK | 0 | $0 | 0 | $0 | 64,480 | $0 |
| 2023 | ANIK | 0 | $0 | 0 | $0 | 69,054 | $0 |
| 2022 | ANIK | 8,100 | $207,254 | 0 | $0 | 38,996 | $0 |
| 2021 | ANIK | 0 | $0 | 0 | $0 | 24,575 | $0 |
| 2020 | ANIK | 0 | $0 | 0 | $0 | 4,231 | $0 |
1. Zimmer Biomet Holdings, Inc. (ZMH)
2. Anika Therapeutics, Inc. (ANIK)
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2012-03-16 | ZMH | Option Ex | 4,368 | .00 | 0 |
| 2012-02-17 | ZMH | Option Ex | 2,794 | .00 | 0 |
| 2012-01-10 | ZMH | Sale | 12,000 | 55.00 | 660,000 |
| 2012-01-10 | ZMH | Option Ex | 12,000 | 39.53 | 474,360 |
| 2011-02-17 | ZMH | Option Ex | 2,794 | .00 | 0 |
| 2011-02-18 | ZMH | Option Ex | 4,000 | 30.19 | 120,760 |
| 2011-02-18 | ZMH | Sale | 4,000 | 65.00 | 260,000 |
| 2009-12-12 | ZMH | Option Ex | 6,813 | .00 | 0 |
| 2008-12-12 | ZMH | Option Ex | 6,812 | .00 | 0 |
| 2007-02-20 | ZMH | Option Ex | 6,000 | 30.19 | 181,140 |
| 2007-02-20 | ZMH | Sale | 6,000 | 86.00 | 516,000 |
| 2007-01-30 | ZMH | Option Ex | 13,856 | 30.66 | 424,783 |
| 2007-01-30 | ZMH | Sale | 13,856 | 83.84 | 1,161,645 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-03-17 | ANIK | Option Ex | 25,132 | .00 | 0 |
| 2025-03-11 | ANIK | Option Ex | 30,060 | .00 | 0 |
| 2025-03-10 | ANIK | Option Ex | 20,002 | .00 | 0 |
| 2024-03-11 | ANIK | Option Ex | 64,480 | .00 | 0 |
| 2023-04-26 | ANIK | Option Ex | 24,575 | .00 | 0 |
| 2023-03-10 | ANIK | Option Ex | 30,060 | .00 | 0 |
| 2023-03-09 | ANIK | Option Ex | 14,419 | .00 | 0 |
| 2022-04-26 | ANIK | Option Ex | 24,576 | .00 | 0 |
| 2022-03-11 | ANIK | Buy | 8,100 | 25.59 | 207,254 |
| 2022-03-09 | ANIK | Option Ex | 14,420 | .00 | 0 |
| 2021-04-26 | ANIK | Option Ex | 24,575 | .00 | 0 |
| 2020-04-26 | ANIK | Option Ex | 4,231 | .00 | 0 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Blanchard Cheryl R (President, CEO, Director of Anika Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.